News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Clearmind Medicine's VP of Business Development Presented at The Canadian Psychedelics Association Event
Clearmind Medicine
Dr. Neil Maresky | CEO, Psyence Group
Psyence Group
atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R-ketamine Program
ATAI Life Sciences
Ketamine One Begins Trading On The OTCQB Marketplace On January 12, 2022
Wellbeing Digital Sciences
Levitee Labs Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals
Levitee Labs
Blackhawk's TERP Wholesale LLC Receives State-Issued Micro-Business License Allowing for Retail Delivery
MindBio Therapeutics
Nova Mentis Provides Corporate Update - 2022 Planned Catalysts
Nova Mentis Life Science
Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development
Field Trip Health
PharmAla Biotech Announces Listing on the Canadian Securities Exchange
Pharmala Biotech Holdings
Braxia Scientific Announces Closing of CAD$3 Million Private Placement
Braxia Scientific Corp.
Ketamine One Subsidiary KGK Science Becomes the First Founding Sponsor of the “Psychedelic Science 2023” Event
Wellbeing Digital Sciences
PsyBio Therapeutics to Present at the H.C. Wainwright Bioconnect Conference
PsyBio Therapeutics
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.